If a novel influenza strain appears and spreads globally, why does prior vaccination against a different strain sometimes offer limited protection?

💡 Explanation

Limited protection arises because while vaccination induces antibody production, a novel strain may possess significantly different surface proteins. Consequently, the existing antibodies' affinity for the new epitopes is too low for effective neutralization; therefore, the virus can still infect cells, rather than being neutralized by the less-effective antibodies.

• In replicating bone marrow cells, what limits continued division, increasing susceptibility to myelodysplastic syndrome?
• A patient with a genetic defect has non-functional cytotoxic T-cells. Why does this immune deficiency increase the risk of virally-induced cancers more than bacterial infections?
• If osteocytes within bone experience reduced mechanical loading due to prolonged bed rest, which consequence follows concerning bone density?
• A musician develops hyperacusis after prolonged exposure to high-intensity sound; which mechanism primarily explains why certain frequencies now trigger disproportionately strong auditory sensations?
• Why does the brainstem trigger increased respiration when the ventilation-perfusion ratio decreases significantly in a lung region affected by localized pneumonia?
• Why does prolonged occlusion of skin via bandages promote opportunistic fungal infection?